ReviewComprehensive reviews in food science and food safety2026
Traditional Fermented Dairy Products as Reservoirs of Bifidobacterium With Probiotic Potential: From Microbial Diversity to Functional Characterization.
Review in Comprehensive reviews in food science and food safety, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
Traditional fermented dairy products (TFDPs) are complex microbial ecosystems that may serve as reservoirs of many microorganisms, including those with probiotic potential such as Bifidobacterium species and lactobacilli. Although bifidobacteria are widely used as probiotic microorganisms in defined formulations, their occurrence, persistence, and functional relevance within TFDPs remain incompletely understood. This review critically synthesizes current evidence on the diversity, ecological roles, and traits associated with probiotic potential of Bifidobacterium spp. detected in TFDPs, including raw-milk fermentations, artisanal dairy products, and selected controlled dairy systems. Species such as Bifidobacterium animalis, Bifidobacterium longum, Bifidobacterium bifidum, and Bifidobacterium breve have been reported across yogurt, kefir, airag (traditional Mongolian fermented dairy beverage from mare milk), and raw milk cheeses, often at low abundance or as transient microbial community members. Many isolates from fermented dairy products exhibit traits commonly associated with probiotic functionality, including acid/bile tolerance, adhesion capacity, exopolysaccharide production, and antimicrobial activity. However, most reports remain limited to presence/absence or in vitro assays, with limited in vivo or clinical validation. Advances in molecular and omics-based approaches have improved detection, characterization, and safety evaluation; however, translation into validated applications remains constrained by challenges in isolation, viability, and strain-level confirmation. Importantly, detection of bifidobacteria in TFDPs does not confer probiotic status, which requires strain-level identification, demonstrated safety, adequate viable counts at consumption, and clinical evidence of health benefit. Collectively, TFDPs, as culturally embedded microbial reservoirs, may support the discovery of novel bifidobacterial strains for future development of functional foods or probiotic products following rigorous validation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.